CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Return on Assets [ROA] (2011 - 2026)

Updated

CytoDyn (CYDY) reported Return on Assets [ROA] of -263.01% for fiscal Q4 2026 (quarter ended May 31, 2026), down 282.10 percentage points from 19.09% a year earlier but up 19.82 percentage points from the prior quarter.

Analysis

CytoDyn (CYDY) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2026 (ended May 31, 2026), CytoDyn posted Return on Assets [ROA] of -266.71%, down 292.37 percentage points from FY2025.

  • Return on Assets [ROA] has a five-year change of -73.42 percentage points (FY2021 to FY2026).
  • By fiscal year, Return on Assets [ROA] came in at 25.67% in FY2025 (+470.12 pp), -444.45% in FY2024 (-50.04 pp), -394.42% in FY2023 (-132.96 pp) and -261.46% in FY2022 (-68.17 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -1338.27% in fiscal Q3 2023 and a high of 19.09% in fiscal Q4 2025.
  • Year over year, Return on Assets [ROA] has now declined in each of the last four quarters, with an average year-over-year change of +132.21 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was fiscal Q3 2024 (a gain of 808.38 percentage points); the low point was fiscal Q3 2023 (a drop of 1139.29 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -282.83% (Q3 2026), -346.69% (Q2 2026) and -133.35% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 CytoDyn 274.70 Mn 274.70 Mn - -263.01%
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 -263.01%
Feb 28, 2026 -282.83%
Nov 30, 2025 -346.69%
Aug 31, 2025 -133.35%
May 31, 2025 19.09%
Feb 28, 2025 -30.76%
Nov 30, 2024 -53.87%
Aug 31, 2024 -97.26%
May 31, 2024 -465.67%
Feb 29, 2024 -529.88%
Nov 30, 2023 -493.94%
Aug 31, 2023 -594.05%
May 31, 2023 -615.59%
Feb 28, 2023 -1,338.27%
Nov 30, 2022 -974.92%
Aug 31, 2022 -647.72%
May 31, 2022 -342.06%
Feb 28, 2022 -198.98%
Nov 30, 2021 -185.05%
Aug 31, 2021 -161.12%
API Access

CytoDyn Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CYDY&period=max&api_key=YOUR_API_KEY